Daniel D. Burton - Dec 2, 2021 Form 4 Insider Report for Health Catalyst, Inc. (HCAT)

Signature
/s/ Daniel Orenstein, as Attorney-in-Fact
Stock symbol
HCAT
Transactions as of
Dec 2, 2021
Transactions value $
-$1,859,077
Form type
4
Date filed
12/7/2021, 03:13 PM
Previous filing
Sep 8, 2021
Next filing
Dec 9, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HCAT Common Stock Tax liability -$185K -4.41K -1.79% $41.95 242K Dec 2, 2021 Direct F1, F2
transaction HCAT Common Stock Options Exercise $235K +21.8K +9.01% $10.80 264K Dec 3, 2021 Direct
transaction HCAT Common Stock Options Exercise $229K +14.4K +5.47% $15.84 278K Dec 3, 2021 Direct
transaction HCAT Common Stock Sale -$1.04M -25.9K -9.31% $40.28 252K Dec 3, 2021 Direct F3, F4
transaction HCAT Common Stock Sale -$420K -10.1K -4.02% $41.47 242K Dec 3, 2021 Direct F3, F5
transaction HCAT Common Stock Sale -$8.43K -200 -0.08% $42.13 242K Dec 3, 2021 Direct F3, F6
transaction HCAT Common Stock Options Exercise $120K +11.1K +4.6% $10.80 253K Dec 6, 2021 Direct
transaction HCAT Common Stock Options Exercise $93.2K +5.88K +2.32% $15.84 259K Dec 6, 2021 Direct
transaction HCAT Common Stock Sale -$880K -22K -8.49% $40.06 237K Dec 6, 2021 Direct F3, F7

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HCAT Stock Option (Right to Buy) Options Exercise $0 -14.4K -13.21% $0.00 94.8K Dec 3, 2021 Common Stock 14.4K $15.84 Direct F8
transaction HCAT Stock Option (Right to Buy) Options Exercise $0 -21.8K -10.56% $0.00 184K Dec 3, 2021 Common Stock 21.8K $10.80 Direct F9
transaction HCAT Stock Option (Right to Buy) Options Exercise $0 -5.88K -6.2% $0.00 88.9K Dec 6, 2021 Common Stock 5.88K $15.84 Direct F8
transaction HCAT Stock Option (Right to Buy) Options Exercise $0 -11.1K -6.03% $0.00 173K Dec 6, 2021 Common Stock 11.1K $10.80 Direct F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
F2 Represents a weighted average price reported by the broker. These shares were sold as part of a block trade in multiple transactions at prices ranging from $40.33 to $42.76, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote with regard to the block trade.
F3 The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on March 4, 2021, in accordance with Rule 10b5-1.
F4 Represents the weighted average sale price of the shares sold ranging from $40.00 to $40.92 per share, inclusive.
F5 Represents the weighted average sale price of the shares sold ranging from $41.09 to $41.79 per share, inclusive.
F6 Represents the weighted average sale price of the shares sold ranging from $42.10 to $42.36 per share, inclusive.
F7 Represents the weighted average sale price of the shares sold ranging from $40.00 to $40.35 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (4) through (7).
F8 25% of the 299,748 shares underlying the option vested in an annual installment on February 5, 2020 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on February 5, 2023.
F9 25% of the 747,223 shares underlying the option vested in an annual installment on September 25, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on September 25, 2022.